Burodiline

This classification denotes a vasodilating agent with the molecular formula C19H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4006BCR8NJ, chemically known as 2-(1-pyrrolidinyl)ethyl 4-butoxy-3,5-dimethoxybenzoat but generally known as burodiline, which bears US NIH Compound Identifier 189887. European Medicines Agency schedules Burodiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05990MIG. The term BURODILINE is an International Non-Proprietary Name. BURODILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule burodiline under HS 29339990 and SITC 51577. As of Q4 2014, BURODILINE remains the US FDA Preferred Term for this commodity. Burodiline bears US NLM identifiers UMLS ID C2698571 and NCI Concept Code C74424. SMILES: O(CCN1CCCC1)C(=O)c1cc(OC)c(OCCCC)c(OC)c1.